Paper Review Records
全部论文审稿周期
21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
129
天
Ibrutinib dose modification and effectiveness in Japanese patients with chronic lymphocytic leukemia: a post-hoc analysis of the Orbit study
作者
Yasushi Isobe; Tsuyoshi Muta; Yosuke Masamoto; Go Yamamoto; Shingo Kurahashi; Yoshihiro Kameoka; Shuichi Ota; Eri Matsuki; Kazutaka Ozeki; Takanori Toyama; Naoki Takahashi; Takahiro Kumode; Nobuyuki Aotsuka; Takuro Yoshimura; Hideto Tamura; Ai Omi; Kazuhiro Shibayama; Yuma Fujimori; Kensuke Kojima; Jun Takizawa; Hirokazu Nagai; Junji Suzumiya; Sadao Aoki展开收起
作者单位
1. Department of Medical Oncology, Hematology and Infectious Diseases, Fukuoka University Hospital; 2. Department of Transfusion Medicine Clinical Laboratory, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital; 3. Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital; 4. Department of Hematology, Toranomon Hospital; 5. Department of Hematology and Oncology, Toyohashi Municipal Hospital; 6. Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine and Faculty of Medicine; 7. Department of Hematology, Akita Red Cross Hospital; 8. Department of Hematology, Sapporo Hokuyu Hospital; 9. Division of Hematology, Department of Medicine, Keio University School of Medicine; 10. Department of Hematology and Oncology, JA Aichi Konan Kosei Hospital; 11. Department of Internal Medicine, Miyazaki Prefectural Nobeoka Hospital; 12. Department of Hematology, International Medical Center, Saitama Medical University; 13. Department of Hematology and Rheumatology, Kindai University Hospital; 14. Department of Hematology and Oncology, Japanese Red Cross Narita Hospital; 15. Department of Hematology, Osaka City General Hospital; 16. Department of Hematology, Dokkyo Medical University Saitama Medical Center; 17. Department of Hematology, Nippon Medical School; 18. Department of Medical Affairs, Johnson & Johnson Innovative Medicine; 19. Statistics & Decision Sciences Japan, Johnson & Johnson Innovative Medicine; 20. Department of Hematology, Kochi Medical School, Kochi University; 21. Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine; 22. Department of Hematology, National Hospital Organization Nagoya Medical Center; 23. Department of Hematology, Koga Community Hospital; 24. Department of Medical Technology, Faculty of Medical Technology, Niigata University of Pharmacy and Medical and Life Sciences; 25. Department of Hematology, Niigata Minami Hospital展开收起
35
天
Acute promyelocytic leukemia with clonal hematopoiesis: a case study of APL in complete molecular remission transitioning to MDS/MPN and its clinical implications
作者
Anetta Marcinek; Katrin Schweneker; Manja Meggendorfer; Torsten Haferlach; Frank Dicker展开收起
作者单位
1. MLL Munich Leukemia Laboratory展开收起
64
天
82
天
The APLC 2025 consensus recommendations on the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia
作者
Carol Yuk Man Cheung; Nurul Aidah Abdul Halim; Gin Gin Gan; Ying Wang; Hein Than; Jie Jin; Bor Sheng Ko; Soo Min Lim; Wasithep Limvorapitak; Ting Liu; Pak Ling Lui; Melissa Gaik Ming Ooi; Sreekanth Sampath Venkata; Adisak Tantiworawit; Gee Chuan Wong; Su Peng Yeh; Jae-Ho Yoo; Ashley P. Ng展开收起
作者单位
1. Queen Mary Hospital; 2. Singapore General Hospital; 3. University Malaya Medical Centre; 4. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences; 5. First Affiliated Hospital of Zhejiang University College of Medicine; 6. National Taiwan University Hospital; 7. Hospital Sultanah Aminah; 8. Thammasat University Hospital; 9. West China Hospital of Sichuan University; 10. National University Cancer Institute; 11. Tan Tock Seng Hospital; 12. Chiang Mai University Hospital; 13. China Medical University Hospital; 14. Seoul St Mary’s Hospital, The Catholic University of Korea; 15. Peter MacCallum Cancer Centre; 16. The Royal Melbourne Hospital展开收起
69
天
Lower baseline eosinophil counts are associated with inferior survival in Mantle cell lymphoma
作者
Kacper Kopeć; Mateusz Fałek; Julia Piotrowska; Adrian Ławski; Julia Rojek; Kacper Pawlak; Maria Woźniak; Marta Czajkowska; Olga Raczyńska; Tadeusz Robak; Jan Wojdal; Paweł Robak; Joanna Góra-Tybor; Damian Mikulski展开收起
作者单位
1. Department of Hemato-Oncology and Internal Medicine, Copernicus Memorial Hospital; 2. Department of Hematology, Medical University of Lodz; 3. Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital; 4. Department of General Hematology and Internal Medicine, Provincial Multi-Specialized Oncology and Trauma Center; 5. Department of Hematology and Transplantology, Copernicus Memorial Hospital展开收起
195
天
Single-Cell RNA sequencing analysis of cellular heterogeneity and microenvironment-driven signaling networks in acute myeloid leukemia
作者
Lo-Jei Ching; Chia-Hao Wang; Wen-Liang Lo; Yu-Jou Cheng; Huan Ou-Yang; Yuan-Tzu Lan; Pin-I Huang; Yi-Wei Chen; Yen-Hung Yao; Shih-Hwa Chiou; Yi-Ping Yang; Ping-Hsing Tsai; Po-Shen Ko展开收起
作者单位
1. Department of Medical Research, Taipei Veterans General Hospital; 2. Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University; 3. School of Medicine, College of Medicine, National Yang Ming Chiao Tung University; 4. Department of Stomatology, Taipei Veterans General Hospital; 5. Department of Surgery, Taipei Veterans General Hospital; 6. Department of Heavy Particles and Radiation Oncology, Taipei Veterans General Hospital; 7. Department of Internal Medicine, National Yang Ming Chiao Tung University Hospital; 8. Institute of Traditional Medicine, National Yang Ming Chiao Tung University; 9. Division of Hematology, Department of Medicine, Taipei Veterans General Hospital展开收起
FAQ
LEUKEMIA & LYMPHOMA审稿要多久?
截至2026-11-19,CrushSCI 收录了 LEUKEMIA & LYMPHOMA 的 21 篇完整审稿记录。最快一篇从收稿到录用用了 2 天(The role of radiotherapy in bridging to CAR T-cell therapy for high-grade B-cell lymphoma,2026-06-19 收稿,2026-06-21 录用),最慢一篇用了 195 天;平均 78.1 天,中位数 69 天。最快这篇的日期间隔异常短,建议点开原文核对。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
